Quantitative effects of sodium–glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients

The aim of the present study is to investigate the quantitative effects of sodium–glucose cotransporter-2 (SGLT-2) inhibitors on the quality of life in heart failure (HF) patients. A total of 14,674 HF patients from two dapagliflozin and three empagliflozin studies is included for analysis via the n...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong-Dong, Zhang, Cun, Zhu, Ping, He, Su-Mei, Chen, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742417/
https://www.ncbi.nlm.nih.gov/pubmed/36518672
http://dx.doi.org/10.3389/fphar.2022.910858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742417/
https://www.ncbi.nlm.nih.gov/pubmed/36518672
http://dx.doi.org/10.3389/fphar.2022.910858

Ejemplares similares